Related Experiment Video
Updated: Jul 10, 2026

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
Published on: May 6, 2013
Immune Checkpoint Inhibitor-Associated Autoimmune Diabetes Mellitus: An Indian Case Series
Medha N Rao1, Aditi Chopra1, Aditya G Hegde1
1Diabetes and Endocrinology, Manipal Hospital, Bangalore, IND.
Immune checkpoint inhibitors can cause autoimmune diabetes (CIADM), a rare but serious condition. Early glucose and ketone monitoring during ICI therapy is crucial for timely detection and preventing diabetic ketoacidosis (DKA).
Area of Science:
- Endocrinology
- Oncology
- Immunology
Background:
- Immune checkpoint inhibitors (ICI) revolutionized cancer treatment but can cause immune-related adverse events (irAEs).
- Checkpoint inhibitor-associated autoimmune diabetes mellitus (CIADM) is a rare, severe irAE characterized by abrupt insulin deficiency and diabetic ketoacidosis (DKA).
More Related Videos
11:31High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model
Published on: August 16, 2019
06:50A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
Published on: May 29, 2020
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Introduction
Type I Diabetes I: Introduction
Type I Diabetes II: Pathophysiology
Type I Diabetes III: Clinical Manifestations
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis